AI Summary & Key Takeaways
AI InsightIn the setting of high bleeding risk, CDT seems to be an effective and safe approach in patients with intermediate‑risk PE.
📌 3 Key Takeaways
Özet
Since December 2019, the novel coronavirus (COVID‑19) outbreak has become an important public health problem and one of the most common causes of morbidity and mortality worldwide. COVID‑19 is highly associated with thromboembolic events, like deep venous thrombosis and pulmonary embolism (PE). Catheter‑directed thrombolysis (CDT) provides effective reperfusion for the treatment of PE. We report a patient who was presented with intermediate‑risk PE and had a saccular aneurysm of the anterior cerebral artery. The patient was suffered from recent COVID‑19 infection and ischemic stroke. As the patient had high bleeding risk for full‑dose systemic thrombolytic therapy, CDT was the preferred method for reperfusion. Finally, the patient was discharged from the hospital uneventfully 4 days later. In the setting of high bleeding risk, CDT seems to be an effective and safe approach in patients with intermediate‑risk PE.